PEDF and VEGF plasma level alterations in patients with dry form of age-related macular degeneration - A possible link to the development of the disease

Klinika Oczna

Volumn 114, Issue 2, 2012, Pages 115-120

  Anna, Machalińska ^a   Krzysztof, Safranow ^a   Katarzyna, Mozolewska Piotrowska ^a   Violetta, Dziedziejko ^a   Danuta, Karczewicz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Pigment epithelium derived factor; Vascular endothelial growth factor

Indexed keywords

EID: 84866996924     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Augood CA, Vingerling JR, De Jong PT, Chakravarthy U, Seland J, Soubrane G et al.: Prevalence of age-related maculopathy in older Europeans: the European Eye Study. Arch Ophthalmol 2006, 124, 529-535.
2. Ambati J, Ambati BK, Yoo SH, Janchulev S, Adamis AP: Agerelated macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003, 48, 257-293. (Pubitemid 36553096)
3. Gehrs KM, Anderson DH, Johnson LV, Hageman GS: Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann Med 2006, 38, 450-471. (Pubitemid 44767496)
4. Tong JP, Yao YF: Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clin Biochem 2006, 39, 267-276.
5. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E: Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995, 72, 638-645.
6. Aiello LR Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST et al.: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 331, 1480-1487. (Pubitemid 24356306)
7. Tsai DC, Charng MJ, Lee FL, Hsu WM, Chen SJ: Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. Ophthalmologica 2006, 220, 246-251.
8. Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY: Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology 2001, 108, 705-710. (Pubitemid 32238466)
9. Thill M, Strunnikova NV, Berna MJ, Gordiyenko N, Schmid K, Cousins SW et al.: Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 2008, 49, 2696-2708.
10. Duh EJ, Yang HS, Haller JA, De Juan E, Humayun MS, Gehlbach P et al.: Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol 2004, 137, 668-674. (Pubitemid 38446681)
11. Barnstable CJ, Tombran-Tink J: Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential. Prog Retin Eye Res 2004, 23, 561-577. (Pubitemid 39078362)
12. Ogata N, Imaizumi M, Miyashiro M et al.: Low levels of pigment epithelium-derived factor in highly myopic eyes with chorioretinal atrophy. Am J Ophthalmol 2005, 140, 937-939. (Pubitemid 41727701)
13. Ohno-Matsui K, Morita I, Tombran-Tink J, Mrazek D, Onbdera M, Uetama T et al.: Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol 2001, 189, 323-333. (Pubitemid 33063300)
14. Holekamp NM, Bouck N, Volpert O: Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol 2002, 134, 220-227. (Pubitemid 34831826)
15. Renno RZ, Youssri AI, Michaud N, Gragoudas ES, Miller JW: Expression of pigment epithelium-derived factor in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2002, 43, 1574-1580. (Pubitemid 34462660)
16. Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP et al.: Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006, 141, 456-462. (Pubitemid 43265948)
17. Matsuoka M, Ogata N, Otsuji T, Nishimura T, Takahashi K, Matsumura M: Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy. Br J Ophthalmol 2004, 88, 809-815. (Pubitemid 38725593)
18. Ogata N, Wada M, Otsuji T, Jo N, Tombran-Tink J, Matsumura M: Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2002, 43, 1168-1175. (Pubitemid 34258289)
19. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W et al.: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999, 285, 245-248. (Pubitemid 29329995)
20. Ohno-Matsui K, Yoshida T, Uetama X, Mochizuki M, Morita I: Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells. Biochem Biophys Res Commun 2003, 303, 962-967. (Pubitemid 36384949)
21. Martin G, Schlunck G, Hansen LL, Agostini HT: Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 2004, 242, 321-326. (Pubitemid 38647606)
22. Bhutto IA, McLeod DS, Hasegawa T, Kim SY, Merges C, Tong P et al.: Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res 2006, 82, 99-110. (Pubitemid 43063401)
23. Apte RS, Barreiro RA, Duh E, Volpert O, Ferguson TA: Stimulation of neovascularization by the anti-angiogenic factor PEDF. Invest Ophthalmol Vis Sci 2004, 45, 4491-4497. (Pubitemid 39564676)